Search - tctmd.com

Displaying 221 - 240 of 284

Sort: Relevancy | Date

Presentation TCT 2016

Czech Republic Presents: How Did I Treat This Case?

Presenter: Eric Van Belle, Jochen Wöhrle, Marian Branny

October 30, 2016

Presentation TCT 2016

Poland Responds: How Would I Treat This Case?

Presenter: Eric Van Belle, Jochen Wöhrle, Marek Grygier

October 30, 2016

Presentation TCT 2016

Czech Republic Presents: A Case of Ostial LAD Undergoing TAVR: Staged or Single Procedure?

Presenter: Eric Van Belle, Jochen Wöhrle, Marian Branny

October 30, 2016

Presentation TCT 2016

France Presents: How Did I Treat This Case?

Presenter: Eric Van Belle, Jochen Wöhrle, Flavien Vincent

October 30, 2016

Presentation TCT 2016

France Presents: A Patient With Critical CAD and Aortic Stenosis Undergoing TAVR: Staged or Single Procedure?

Presenter: Eric Van Belle, Jochen Wöhrle, Flavien Vincent

October 30, 2016

Presentation TCT 2016

Poland Presents: Treatment Options - Should Severe Coronary Artery Disease Be Treated Prior, During, or After TAVR (and in a Single or Staged Procedure)?

Presenter: Eric Van Belle, Jochen Wöhrle, Dariusz Dudek

October 30, 2016

Presentation TCT 2016

Introduction and Session Objectives

Presenter: Eric Van Belle, Jochen Wöhrle

October 30, 2016

Presentation TCT 2016

The Evolution of Therapies for Coronary Artery Disease and Valve Disorders in My Lifetime

Presenter: A. Pieter Kappetein

October 30, 2016

Presentation TCT 2016

Valvular Heart Disease: Diagnosis and Treatment Options

Presenter: Peter Barlis, Grzegorz L. Kaluza, Nicola Corvaja

October 29, 2016

Presentation TCT 2016

Coronary Artery Disease: Pathology and Pathogenesis

Presenter: Peter Barlis, Grzegorz L. Kaluza

October 29, 2016

Presentation

Migraine and Risk of Cardiovascular Disease in Women: Prospective Cohort Study

Presenter: Tobias Kurth

June 02, 2016

Presentation

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Presenter: R. Khatib

October 26, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Presenter: Nabil Dib, Philippe Menasché, Marc S. Penn

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Jay H Traverse

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Amit Patel

October 15, 2015

Presentation TCT 2015

New Noninvasive Methods for Assessing Valvular Heart Disease

Presenter: Jeroen J. Bax, Paul A. Grayburn

October 15, 2015

Presentation TCT 2015

Assessing Postdevice Paravalvular Aortic Regurgitation

Presenter: Jeroen J. Bax, Paul A. Grayburn, Rebecca T. Hahn

October 15, 2015

Presentation TCT 2015

What Defines Severe MR Post-AHA/ACC Guidelines?

Presenter: Jeroen J. Bax, Paul A. Grayburn

October 15, 2015

Presentation TCT 2015

Low-Flow, Low-Gradient Aortic Stenosis: How to Diagnosis, and Should We Treat?

Presenter: Jeroen J. Bax, Paul A. Grayburn, Philippe Pibarot

October 15, 2015

Advertisement

Czech Republic Presents: How Did I Treat This Case?

Poland Responds: How Would I Treat This Case?

Czech Republic Presents: A Case of Ostial LAD Undergoing TAVR: Staged or Single Procedure?

France Presents: How Did I Treat This Case?

France Presents: A Patient With Critical CAD and Aortic Stenosis Undergoing TAVR: Staged or Single Procedure?

Poland Presents: Treatment Options - Should Severe Coronary Artery Disease Be Treated Prior, During, or After TAVR (and in a Single or Staged Procedure)?

Introduction and Session Objectives

The Evolution of Therapies for Coronary Artery Disease and Valve Disorders in My Lifetime

Valvular Heart Disease: Diagnosis and Treatment Options

Coronary Artery Disease: Pathology and Pathogenesis

Migraine and Risk of Cardiovascular Disease in Women: Prospective Cohort Study

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

New Noninvasive Methods for Assessing Valvular Heart Disease

Assessing Postdevice Paravalvular Aortic Regurgitation

What Defines Severe MR Post-AHA/ACC Guidelines?

Low-Flow, Low-Gradient Aortic Stenosis: How to Diagnosis, and Should We Treat?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content